Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data

Detalles Bibliográficos
Autores principales: DeJesus, E, Mills, A, Bhatti, L, Conner, C, Storfer, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113042/
http://dx.doi.org/10.1186/1758-2652-13-S4-P4
_version_ 1782205874885885952
author DeJesus, E
Mills, A
Bhatti, L
Conner, C
Storfer, S
author_facet DeJesus, E
Mills, A
Bhatti, L
Conner, C
Storfer, S
author_sort DeJesus, E
collection PubMed
description
format Online
Article
Text
id pubmed-3113042
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-31130422011-06-13 Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data DeJesus, E Mills, A Bhatti, L Conner, C Storfer, S J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113042/ http://dx.doi.org/10.1186/1758-2652-13-S4-P4 Text en Copyright ©2010 DeJesus et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
DeJesus, E
Mills, A
Bhatti, L
Conner, C
Storfer, S
Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
title Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
title_full Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
title_fullStr Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
title_full_unstemmed Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
title_short Nevirapine (NVP) vs ritonavir-boosted atazanavir (ATV/r) combined with tenofovir/emtricitabine (TDF/FTC) in first-line therapy: NEWART 48-week data
title_sort nevirapine (nvp) vs ritonavir-boosted atazanavir (atv/r) combined with tenofovir/emtricitabine (tdf/ftc) in first-line therapy: newart 48-week data
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113042/
http://dx.doi.org/10.1186/1758-2652-13-S4-P4
work_keys_str_mv AT dejesuse nevirapinenvpvsritonavirboostedatazanaviratvrcombinedwithtenofoviremtricitabinetdfftcinfirstlinetherapynewart48weekdata
AT millsa nevirapinenvpvsritonavirboostedatazanaviratvrcombinedwithtenofoviremtricitabinetdfftcinfirstlinetherapynewart48weekdata
AT bhattil nevirapinenvpvsritonavirboostedatazanaviratvrcombinedwithtenofoviremtricitabinetdfftcinfirstlinetherapynewart48weekdata
AT connerc nevirapinenvpvsritonavirboostedatazanaviratvrcombinedwithtenofoviremtricitabinetdfftcinfirstlinetherapynewart48weekdata
AT storfers nevirapinenvpvsritonavirboostedatazanaviratvrcombinedwithtenofoviremtricitabinetdfftcinfirstlinetherapynewart48weekdata

Ejemplares similares